Jia Biyou (688089.SH) announced that the company received it from the China Securities Regulatory Commission on May 15, 2024...
Zhitong Finance App News, Jiabiyou (688089.SH) announced that on May 15, 2024, the company received the “Decision of the Hubei Securities Regulatory Bureau on Measures to Issue Warning Letters against Jiabiyou Biotechnology (Wuhan) Co., Ltd., Yi Dewei, Yi Huarong, and Wang Huabiao” ([2024] No. 24) (“Warning Letter”) issued by the Hubei Regulatory Bureau of the China Securities Regulatory Commission.
Jiabiyou Biotechnology (Wuhan) Co., Ltd., Yi Dewei, Yi Huarong, Wang Huabiao: During daily supervision, our bureau discovered that Jiabiyou Biotechnology (Wuhan) Co., Ltd. (Jiabiyou or Company for short) committed the following violations: On December 27, 2023, the company used idle raised funds to purchase financial management products such as time deposits on December 28, 2023, January 2, 2024, and January 16, 2024, respectively, when the authorization to purchase financial management products such as time deposits expired. The company failed to comply with the review procedures and information disclosure obligations in a timely manner, and the board of directors meeting on February 28, 2024 did not confirm, supplement, and disclose it to the outside world.
Jia Biyou's above actions violate the provisions of Article 3 (1) of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182). Yi Dewei, the director and general manager of the company, Yi Huarong as the secretary of the company's board of directors, and Wang Huabiao as the company's financial director, failed to fulfill the obligation of diligence and due diligence in accordance with section 51 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182), and bears the main responsibility for the company's irregularities. According to the provisions of Article 52 (3) of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182), our bureau decided that Jiabiyou Biotechnology (Wuhan) Co., Ltd., Yi Dewei, Yi Huarong, and Wang Huabiao will take administrative supervision measures to issue a warning letter and record it in the securities and futures market integrity file. The company and relevant responsible persons should fully learn the lessons, and Du Chun's behavior occurred again.